Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Non Operating Income (2016 - 2026)

Ekso Bionics Holdings has reported Non Operating Income over the past 14 years, most recently at -$1.8 million for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 54.02% to -$1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.3 million, a 47.82% decrease, with the full-year FY2025 number at -$26000.0, up 97.01% from a year prior.
  • Non Operating Income reached -$1.8 million in Q4 2025 per EKSO's latest filing, down from -$5000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $2.1 million in Q2 2021, with the low at -$1.8 million in Q4 2025.
  • The 5-year median for Non Operating Income is -$2000.0 (2021), against an average of $62100.0.
  • Peak YoY movement for Non Operating Income: crashed 32400.0% in 2022, then skyrocketed 18800.0% in 2024.
  • Tracing EKSO's Non Operating Income over 5 years: stood at $1.7 million in 2021, then crashed by 71.88% to $475000.0 in 2022, then plummeted by 108.0% to -$38000.0 in 2023, then tumbled by 3013.16% to -$1.2 million in 2024, then plummeted by 54.02% to -$1.8 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$1.8 million, -$5000.0, and -$8000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.